{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:42Z","timestamp":1790015502849,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jaci.2009.11.031","type":"journal-article","created":{"date-parts":[[2010,1,2]],"date-time":"2010-01-02T04:03:56Z","timestamp":1262405036000},"page":"85-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009"],"prefix":"10.1016","volume":"125","author":[{"given":"Scott H.","family":"Sicherer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Y.M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2009.11.031_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaci.2009.02.004","article-title":"Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal","volume":"123","author":"Ben-Shoshan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaci.2008.12.1116","article-title":"Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007","volume":"123","author":"Mullins","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jaci.2009.01.045","article-title":"Update on allergies in pregnancy, lactation, and early childhood","volume":"123","author":"Pali-Scholl","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2008.12.014","article-title":"Household peanut consumption as a risk factor for the development of peanut allergy","volume":"123","author":"Fox","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaci.2008.12.1126","article-title":"Association of obesity with IgE levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005-2006","volume":"123","author":"Visness","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaci.2008.10.011","article-title":"Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model","volume":"123","author":"Ganeshan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaci.2008.10.001","article-title":"Targeting IL-4\/IL-13 signaling to alleviate oral allergen-induced diarrhea","volume":"123","author":"Brandt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2008.12.1115","article-title":"Antigen-primed splenic CD8+ T cells impede the development of oral antigen-induced allergic diarrhea","volume":"123","author":"Yamada","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaci.2008.11.004","article-title":"Peanuts can contribute to anaphylactic shock by activating complement","volume":"123","author":"Khodoun","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaci.2009.03.012","article-title":"Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions","volume":"124","author":"Arias","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaci.2009.08.024","article-title":"Maternal peanut exposure during pregnancy and lactation reduces peanut allergy risk in offspring","volume":"124","author":"Lopez-Exposito","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaci.2008.09.051","article-title":"Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein","volume":"123","author":"Shreffler","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaci.2008.12.1128","article-title":"Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy","volume":"123","author":"Wanich","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2008.09.012","article-title":"Allergenicity and antigenicity of fenugreek (Trigonella foenum-graecum) proteins in foods","volume":"123","author":"Faeste","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2009.02.010","article-title":"Characterization of the allergic T-cell response to Pru p 3, the nonspecific lipid transfer protein in peach","volume":"124","author":"Schulten","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaci.2009.04.016","article-title":"Sarcoplasmic calcium-binding protein is an EF-hand-type protein identified as a new shrimp allergen","volume":"124","author":"Ayuso","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2009.05.024","article-title":"Development of a novel peptide microarray for large-scale epitope mapping of food allergens","volume":"124","author":"Lin","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaci.2008.09.034","article-title":"Soybean (Glycine max) allergy in Europe: Gly m 5 (beta-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy","volume":"123","author":"Holzhauser","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jaci.2009.07.033","article-title":"Assessment of component-resolved in vitro diagnosis of celeriac allergy","volume":"124","author":"Bauermeister","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaci.2009.02.023","article-title":"Pru p 3 as a marker for symptom severity for patients with peach allergy in a birch pollen environment","volume":"124","author":"Gaier","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2009.02.005","article-title":"Component-resolved in vitro diagnosis of hazelnut allergy in Europe","volume":"123","author":"Hansen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2009.05.031","article-title":"Relevance of IgE binding to short peptides for the allergenic activity of food allergens","volume":"124","author":"Albrecht","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaci.2009.10.006","article-title":"Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children","volume":"124","author":"J\u00e4rvinen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib24","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1016\/j.jaci.2009.03.042","article-title":"Work Group report: oral food challenge testing","volume":"123","author":"Nowak-Wegrzyn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2008.10.052","article-title":"Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose","volume":"123","author":"Commins","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jaci.2009.06.014","article-title":"Mammalian meat-induced anaphylaxis: clinical relevance of anti-galactose-alpha-1,3-galactose IgE confirmed by means of skin tests to cetuximab","volume":"124","author":"Jacquenet","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2009.05.032","article-title":"Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities","volume":"124","author":"Pieretti","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2008.12.1125","article-title":"Accidental allergic reactions in children allergic to cow's milk proteins","volume":"123","author":"Boyano-Martinez","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaci.2009.04.004","article-title":"Management of food allergies in schools: a perspective for allergists","volume":"124","author":"Young","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaci.2009.06.039","article-title":"Self-reported allergic reactions to peanut and tree nuts occurring on commercial airlines","volume":"124","author":"Greenhawt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaci.2009.05.028","article-title":"Food allergy and food allergy attitudes among college students","volume":"124","author":"Greenhawt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaci.2009.06.033","article-title":"Adrenaline (epinephrine) autoinjector use in preschools","volume":"124","author":"Joshi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2009.08.045","article-title":"Assessment of psychological distress among children and adolescents with food allergy","volume":"124","author":"LeBovidge","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","article-title":"Clinical efficacy and immune regulation with peanut oral immunotherapy","volume":"124","author":"Jones","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2009.03.045","article-title":"Safety of a peanut oral immunotherapy protocol in children with peanut allergy","volume":"124","author":"Hofmann","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib36","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jaci.2009.09.042","article-title":"Adverse reactions during peanut oral immunotherapy home dosing","volume":"124","author":"Varshney","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaci.2009.06.025","article-title":"Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy","volume":"124","author":"Narisety","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaci.2008.12.1107","article-title":"Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells","volume":"123","author":"Srivastava","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaci.2009.03.020","article-title":"IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor","volume":"124","author":"Behnecke","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2008.10.049","article-title":"Anaphylaxis fatalities and admissions in Australia","volume":"123","author":"Liew","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jaci.2009.08.025","article-title":"Anaphylaxis: recent advances in assessment and treatment","volume":"124","author":"Simons","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2009.03.050","article-title":"Anaphylaxis in the community: learning from the survivors","volume":"124","author":"Simons","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase\u2014a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib44","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib45","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaci.2009.03.017","article-title":"Venom immunotherapy reduces large local reactions to insect stings","volume":"123","author":"Golden","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaci.2008.09.023","article-title":"Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy","volume":"123","author":"Saverino","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2009.05.026","article-title":"The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract","volume":"124","author":"Roumana","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2008.11.009","article-title":"Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy","volume":"123","author":"Maintz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2009.02.031","article-title":"Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins","volume":"124","author":"Atanaskovic-Markovic","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib50","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","article-title":"Risk\u00a0stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management","volume":"123","author":"Hesterberg","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib51","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2008.09.046","article-title":"A desensitization protocol for the mAb cetuximab","volume":"123","author":"Jerath","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib53","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to monoclonal antibodies: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl 2","key":"10.1016\/j.jaci.2009.11.031_bib54","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaci.2009.07.013","article-title":"Filaggrin in atopic dermatitis","volume":"124","author":"O'Regan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaci.2009.07.041","article-title":"Our evolving understanding of the functional role of filaggrin in atopic dermatitis","volume":"124","author":"Leung","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib56","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jaci.2009.03.036","article-title":"Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease","volume":"123","author":"Rodriguez","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib57","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2008.12.562","article-title":"Variants in the tight junction gene, claudin-1 are associated with atopic dermatitis in two American populations and may contribute to skin barrier dysfunction","volume":"123","author":"De Benedetto","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib59","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad defects in epidermal cornification in atopic dermatitis (AD) identified through genomic analysis","volume":"124","author":"Guttman-Yassky","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jaci.2009.03.046","article-title":"Risk\u00a0analysis of early childhood eczema","volume":"123","author":"Bisgaard","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2009.06.052","article-title":"Gestational diabetes, atopic dermatitis, and allergen sensitization in early childhood","volume":"124","author":"Kumar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib62","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2009.05.020","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum","volume":"124","author":"Beck","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaci.2008.04.022","article-title":"Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3","volume":"122","author":"Kisich","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2009.11.031_bib65","first-page":"S34","article-title":"Abnormal immune responses to herpes simplex in subjects with atopic dermatitis complicated by eczema herpeticum","volume":"123","author":"Leung","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaci.2009.05.002","article-title":"Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain","volume":"124","author":"Bin","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2008.10.031","article-title":"IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response","volume":"123","author":"Eyerich","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib68","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2008.10.008","article-title":"Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA","volume":"123","author":"Kinoshita","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2009.11.031_bib70","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jaci.2008.12.239","article-title":"Genetic variants in TSLP and its receptor, IL7R, contribute to an increased risk for atopic dermatitis and eczema herpeticum in two American populations","volume":"123","author":"Gao","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib71","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jaci.2009.07.004","article-title":"Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis","volume":"124","author":"Gros","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2009.04.026","article-title":"IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes","volume":"124","author":"Wittmann","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaci.2009.05.015","article-title":"Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema","volume":"124","author":"Zeller","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib74","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaci.2009.07.057","article-title":"Peeling off the layers: skin taping and a novel proteomics approach to study atopic dermatitis","volume":"124","author":"Broccardo","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib75","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jaci.2009.06.046","article-title":"Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens","volume":"124","author":"Scharschmidt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib76","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2009.05.042","article-title":"Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen","volume":"124","author":"Oyoshi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib77","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2009.07.040","article-title":"Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13","volume":"124","author":"He","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib78","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jaci.2009.02.007","article-title":"Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization","volume":"123","author":"Jin","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib79","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaci.2009.04.029","article-title":"Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity","volume":"124","author":"Honda","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaci.2009.04.025","article-title":"DNA vaccination against macrophage migration inhibitory factor improves atopic dermatitis in murine models","volume":"124","author":"Hamasaka","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib81","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaci.2008.09.042","article-title":"Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights","volume":"122","author":"Jung","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib83","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2009.03.032","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"123","author":"Jensen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib84","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaci.2009.02.028","article-title":"Lymphoma among patients with atopic dermatitis and\/or treated with topical immunosuppressants in the United Kingdom","volume":"123","author":"Arellano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib85","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2009.07.056","article-title":"Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis","volume":"124","author":"Hijnen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib86","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2009.01.043","article-title":"UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo","volume":"123","author":"Gl\u00e4ser","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib87","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jaci.2008.12.1130","article-title":"A survey of allergists regarding the association of thyroid autoimmunity with chronic urticaria","volume":"123","author":"Sheikh","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib88","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2008.09.005","article-title":"Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years","volume":"123","author":"Setkowicz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib89","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2008.11.040","article-title":"Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria","volume":"123","author":"Metz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib90","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaci.2008.10.050","article-title":"What the first 10,000 patients with chronic urticaria have taught me: a personal journey","volume":"123","author":"Kaplan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib91","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","article-title":"High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study","volume":"123","author":"Siebenhaar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib92","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jaci.2008.12.005","article-title":"Successful treatment of chronic drug-resistant urticaria with alprazolam","volume":"123","author":"Duenas-Laita","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib93","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2009.06.012","article-title":"Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis","volume":"124","author":"Fukuda","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib94","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2009.03.008","article-title":"Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis","volume":"123","author":"Ueta","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib95","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.11.031_bib96","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaci.2008.12.025","article-title":"Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008","volume":"123","author":"Sicherer","year":"2009","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909017539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909017539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:19:26Z","timestamp":1758788366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674909017539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0091674909017539"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2009.11.031","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2009.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}